Different Expression of μ-Opiate Receptor in Chronic and Acute Wounds and the Effect of β-Endorphin on Transforming Growth Factor β Type II Receptor and Cytokeratin 16 Expression
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (1) , 145-152
- https://doi.org/10.1046/j.1523-1747.2003.12018.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- β-Endorphin Stimulates Cytokeratin 16 Expression and Downregulates μ-Opiate Receptor Expression in Human EpidermisJournal of Investigative Dermatology, 2000
- An Immunocytochemical Approach to the Study of β‐Endorphin Production in Human Keratinocytes using Confocal MicroscopyAnnals of the New York Academy of Sciences, 1999
- Characterization of μ‐Opiate Receptor in Human Epidermis and KeratinocytesAnnals of the New York Academy of Sciences, 1999
- Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skinJournal of Dermatological Science, 1997
- Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.Genes & Development, 1995
- Nerve growth factor modulates keratinocyte proliferation in murine skin organ cultureBritish Journal of Dermatology, 1994
- Local increases of subcutaneous β-endorphin immunoactivity at the site of thermal injuryImmunopharmacology, 1993
- Opioid Analgesia at Peripheral SitesAnesthesia & Analgesia, 1987
- Elevation of Circulating ??-Endorphin Levels with Concomitant Depression of Immune Parameters after Traumatic InjuryPublished by Wolters Kluwer Health ,1986
- A comparison of β-endorphin levels in regenerating and nonregenerating vertebratesJournal of Experimental Zoology, 1983